Document is current
Any future updates will be listed below
-
Authors
Fadini, Gian Paolo https://orcid.org/0000-0002-6510-2097
- License Information
-
More Information
Article History
Received: 7 August 2025
Accepted: 15 August 2025
First Online: 31 August 2025
Declarations
:
: Gian Paolo Fadini received honoraria, consultancy or lecture fees from AstraZeneca, Boehringer, Guidotti, Lilly, Novartis, and Sanofi. GPF is an Editorial Board member of Diabetes Therapy. GPF was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions.
: No ethical approval was sought as this article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by the author.
